Germany

Mon
21
May

The demand for medical marijuana in Germany has skyrocketed over the last year — and it's costing health insurance companies millions

The demand for medical marijuana in Germany has skyrocketed since it was legalised in March last year, placing a greater burden on the country's health insurance providers to cover the cost of prescriptions.

A new report published by German health insurance company Techniker-Krankenkasse, or TK, and the University of Bremen found that as of February nearly 16,000 patients nationwide had applied to be reimbursed for medical marijuana costs, compared to around 1,100 before the law came into effect.

The authors of the "Cannabis Report" also question the medical benefits of cannabis, often touted as an "herbal wonder drug."

Thu
08
Mar

Germany: From ‘skyrocketing’ demand to scepticism: one year of medical marijuana

Since medical marijuana was legalized in Germany in March last year, an increasing number of patients are being prescribed the drug. But the healthcare industry has been less enthusiastic about the boom and many questions have gone unanswered.

Demand for cannabis has shot up since it was legalized about a year ago. Around 44,000 units of the plant covered by health insurance were distributed to patients in 2017, according to figures from the pharmacy association ABDA which were recently shown to the German Press Agency (DPA).

Mon
05
Feb

German police association calls for complete legalization of cannabis

The Association of German Criminal Officers (BDK) has spoken out in favour of ending the ban on cannabis and has called for the decriminalization of all use of the drug.

"The prohibition of cannabis has historically been seen as arbitrary and has not yet been implemented in an intelligent and effective manner,” the head of BDK, André Schulz, told Bild newspaper on Monday.

“In the history of mankind there has never been a society without the use of drugs; this is something that has to be accepted,” he added.

“My prediction is cannabis will not be banned for long in Germany.‎”

The BDK therefore advocates a "complete decriminalization of cannabis use," Schulz said, adding that the current legal system is stigmatizing people and promoting criminal careers.

Fri
02
Feb

Germany may prohibit Medical Cannabis users from owning firearms

A German court has denied a medical cannabis user's appeal to have his firearms license reinstated, creating a precedent that will most likely block German MMJ users from owning guns. The ruling was handed down in the case of a hunter from Miesbach whose hunting and firearms licenses were revoked due to his legal use of medical cannabis. In a statement, authorities said that they made this decision based on an expert opinion stating that the mental well-being of a cannabis user cannot be guaranteed.

Mon
29
Jan

The week in marijuana deals: A factory revival, hemp heats up and destination Germany

The Aurora, Cannimed mega-merger wasn’t the only deal in the marijuana space this past week. Here’s a few you may have missed.

Last week’s weed headlines were dominated by the billion-dollar deal between Aurora Cannabis Inc. and Cannimed Therapeutics Inc., whose management teams came together after months of bickering to lay the groundwork for marijuana’s first mega-merger.

As the drama unfolded, plenty of other deals were getting done across the industry. Here’s a few you may have missed:

Nesting with Nestle

Fri
19
Jan

Why Germans love marijuana to kill pain

This isn’t Cheech and Chong’s weed — Germany’s medical marijuana users are people tired of popping powerful pills to ease pain. Facing a cannabis import crisis, the country is now starting to grow its own.

Chronically and terminally ill patients in Germany can’t get enough cannabis. Demand for medical marijuana has far outstripped supply since becoming legally available early last year to patients suffering from debilitating pain.

Wed
10
Jan

Nuuvera breaks ground on medical cannabis packaging facility in Germany

Nuuvera Deutschland has broken ground on a new facility in Germany for storage and packaging of medical cannabis products.

Located in Bad Bramstedt, in northern Germany, the 11,300ft² facility features security and related technology and will be built in compliance with the most stringent requirements for the storage of controlled substances in Germany and the EU.

Planned to be built in two phases, the storage and packaging facility will help meet the increasing demand for medical cannabis products.

Nuuvera CEO Lorne Abony said that the new facility will help the company in continuing to develop into a major supplier of medical cannabis products to German consumers.

Fri
05
Jan

Harvest One Cannabis stock has plenty of growth potential

Harvest One Cannabis Inc. (TSXV:HVST) is a global cannabis company serving the medical cannabis markets internationally and is preparing to serve the new Canadian recreational cannabis market.

Harvest One Cannabis operates through its two wholly-owned subsidiaries, United Greeneries Holdings Ltd. and Satipharm AG. United Greeneries is based in Vancouver, BC and holds a Canadian ACMPR cultivation and sales license for its 16,000 sq ft facility at Duncan, BC, with 1,000 kg of annual production capacity.

Fri
22
Dec

Germany is burning marijuana tor heat

When it comes to combating the wicked war on weed, it is typical for law enforcement agencies all across the globe to destroy seized marijuana. It is sort of a chubby middle finger buried in the sphincter of the culture of all highness, a combustible sacrifice to the proverbial gods of government, just to let them know that pigs are still running the farm.

But in Germany, where President Trump’s version of American politics was born and bred through occult magick, incestuous orgies and good old-fashioned brute force, police are apparently using the marijuana confiscated from large black market busts to heat the homes of Munich residents.

That’s right, the pigs are turning pot into power.

Fri
29
Sep

No clear evidence of ancestry differences between Sativa- and Indica-labelled cannabis

Cologne, Germany - Cannabis labelled ‘Sativa’ and ‘Indica’ may not come from distinct ancestries, according to a study performed by the Canadian Dalhousie University in cooperation with Bedrocan on the genetic differences between the two types and their hybrids.

In this study 149 Dutch cannabis samples were analysed, correlating the genotype and chemotype to their reported ancestries.

Indica- and Sativa-labelled samples were not as distinct as sub species would be assumed to be, but the genetic differences between them do correlate to their terpene profile (resin fragrance), which could explain the variation between them.

Pages

Subscribe to RSS - Germany